Nanolattix

Nanolattix

Home page

2024.4

Release time:

2025-01-10

Nanolattix T320-ADC Successfully Selected and Signed as a 'Major Special Project' in Shanxi Province!

2024.4

Nanolattix T320-ADC Successfully Selected and Signed as a 'Major Special Project' in Shanxi Province!

Tag:

Previous Page

Next Page

Previous Page:

Next page:

recommend News

Nanolattix Chairperson Dr. Zhican Qu Attends BIO 2025, Showcasing China's Biopharma Innovation

2025-07-09

Clinical Trial Recruitment for T320, a Novel TF-Targeting Anti-Cancer Drug

2025-07-09

Nanolattix’s T320-ADC Multi-Center Clinical Trials Initiated, Accelerating Development of Advanced Solid Tumor Therapies

2025-07-09

Chain-Driven Frontier Nuclear Medicine Innovation | Nanolattix Chairman Qu Zhican Attends BIOCHINA 2026

2026-03-16

Nanolattix's Nuclear Drug RT01 Completes First Dosing in Clinical IIT, Seizing the New High Ground of "RDC + ADC" Theranostics Integration

2026-03-03

Share

Nanolattix

Nanolattix

WeChat Public Number

Copyright©2024 Shanxi Nanolattix Biotechnology Co., Ltd.

Powered by 300.cn | SEO

Business License